Authors: Deneux, C Tardy, V Dib, A Mornet, E Billaud, L Charron, D Morel, Y Kuttenn, F

Citation: C. Deneux et al., Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J CLIN END, 86(1), 2001, pp. 207-213

Authors: Simard, J Ricketts, AL Moisan, AM Tardy, V Peter, M Van Vliet, G Morel, Y

Citation: J. Simard et al., A new insight into the molecular basis of 3 beta-hydroxysteroid dehydrogenase deficiency, ENDOCRINE R, 26(4), 2000, pp. 761-770

Authors: Delague, V Souraty, N Khallouf, E Tardy, V Chouery, E Halaby, G Loiselet, J Morel, Y Megarbane, A

Citation: V. Delague et al., Mutational analysis in Lebanese patients with congenital adrenal hyperplasia due to a deficit in 21-hydroxylase, HORMONE RES, 53(2), 2000, pp. 77-82

Authors: L'Allemand, D Tardy, V Gruters, A Schnabel, D Krude, H Morel, Y

Citation: D. L'Allemand et al., How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency, J CLIN END, 85(12), 2000, pp. 4562-4567

Authors: Moisan, AM Ricketts, ML Tardy, V Desrochers, M Mebarki, F Chaussain, JL Cabrol, S Raux-Demay, MC Forest, MG Sippell, WG Peter, M Morel, Y Simard, J

Citation: Am. Moisan et al., Commentary - New insight into the molecular basis of 3 beta-hydroxysteroiddehydrogenase deficiency: Identification of fight mutations in the HSD3B2 gene in eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes, J CLIN END, 84(12), 1999, pp. 4410-4425